Abstract
We have previously demonstrated that the active vitamin D hormone, 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) and a cis-locked non-genomic analogue, protect skin cells from ultraviolet radiation (UV)-induced skin cell loss, DNA damage, immunosuppression and skin carcinogenesis. Herein, we used a low-calcaemic analogue, 1α-hydroxymethyl-16-ene-24,24-difluoro-25-hydroxy-26,27-bis-homovitamin D3 (QW), which has some transactivating capacity and is approximately 80–100 times less calcaemic than 1,25(OH)2D3. QW (0.1–10 nM) significantly (p < 0.05–0.01) reduced UV-induced DNA lesions (CPD) in skin fibroblasts and keratinocytes and reduced cell death after UV exposure. Moreover, both 1,25(OH)2D3 and QW (1 nM) were equally effective in significantly (p < 0.01) increasing levels of tumour suppressive p53 in cultured human keratinocytes at 3 and 6 h after UV exposure. In a hairless mouse model, both 1,25(OH)2D3 and QW (22.8 ρmol cm−2) reduced UV-immunosuppression from 13.7 ± 1.3% to 0.1 ± 1.1% (p < 0.01) and 5.4 ± 1.5% (p < 0.01) respectively. When tested alongside 1,25(OH)2D3 in a murine model of skin carcinogenesis. QW (22.8 ρmol cm−2) was not as effective as 1α,25(OH)2D3 or a cis-locked analogue in reducing tumour formation or inhibiting tumour progression. It is possible that the dose required for QW to be effective as an anti-photocarcinogenesis agent in vivo is higher than for protection against the acute effects of UV exposure, but the dissociation between clear acute photo-protective effects and limited long term photoprotection is as yet unexplained.
Similar content being viewed by others
References
M. F. Holick, J. A. MacLaughlin, M. B. Clark, S. A. Holick, J. T. Potts, Jr., R. R. Anderson, I. H. Blank, J. A. Parrish and P. Elias, Photosynthesis of previtamin D3 in human skin and the physiologic consequences, Science, 1980, 210, 203–205.
R. B. Setlow, Cyclobutane-type pyrimidine dimers in polynucleotides, Science, 1966, 153, 379–386.
S. Mouret, C. Baudouin, M. Charveron, A. Favier, J. Cadet and T. Douki, Cyclobutane pyrimidine dimers are predominant DNA lesions in whole human skin exposed to UVA radiation, Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 13765–13770.
A. A. Lamola, Production of pyrimidine dimers in DNA in the dark, Biochem. Biophys. Res. Commun., 1971, 43, 893–898.
N. M. Wikonkal and D. E. Brash, Ultraviolet radiation induced signature mutations in photocarcinogenesis, J. Invest. Dermatol. Symp. Proc., 1999, 4, 6–10.
M. L. Kripke, P. A. Cox, L. G. Alas and D. B. Yarosh, Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice, Proc. Natl. Acad. Sci. U. S. A., 1992, 89, 7516–7520.
P. De Haes, M. Garmyn, H. Degreef, K. Vantieghem, R. Bouillon and S. Segaert, 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes, J. Cell. Biochem., 2003, 89, 663–673.
K. M. Dixon, S. S. Deo, A. W. Norman, J. E. Bishop, G. M. Halliday, V. E. Reeve and R. S. Mason, In vivo relevance for photoprotection by the vitamin D rapid response pathway, J. Steroid Biochem. Mol. Biol., 2007, 103, 451–456.
K. M. Dixon, S. S. Deo, G. Wong, M. Slater, A. W. Norman, J. E. Bishop, G. H. Posner, S. Ishizuka, G. M. Halliday, V. E. Reeve and R. S. Mason, Skin cancer prevention: a possible role of 1,25-dihydroxyvitamin D3 and its analogs, J. Steroid Biochem. Mol. Biol., 2005, 97, 137–143.
K. M. Dixon, A. W. Norman, V. B. Sequeira, R. Mohan, M. S. Rybchyn, V. E. Reeve, G. M. Halliday and R. S. Mason, 1alpha,25(OH)2-vitamin D and a non-genomic vitamin D analog inhibit ultraviolet radiation-induced skin carcinogenesis, Cancer Prev Res (Phila), 2011, 4, (9) 1485–1494.
R. Gupta, K. M. Dixon, S. S. Deo, C. J. Holliday, M. Slater, G. M. Halliday, V. E. Reeve and R. S. Mason, Photoprotection by 1,25dihydroxyvitamin D is associated with an increase in p53 and a decrease in nitric oxide products, J. Invest. Dermatol., 2007, 127, 707–715.
G. Wong, R. Gupta, K. M. Dixon, S. S. Deo, S. M. Choong, G. M. Halliday, J. E. Bishop, S. Ishizuka, A. W. Norman, G. H. Posner and R. S. Mason, 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway, J. Steroid Biochem. Mol. Biol., 2004, 89–90, 567–570.
V. Sequeira, M. Rybchyn, W. Tongkao-On, C. Gordon-Thomson, P. Malloy, I. Nemere, A. Norman, V. Reeve, G. Halliday, D. Feldman and R. Mason, The role of the vitamin D receptor and ERp57 in photoprotection by 1α,25-dihydroxyvitamin D3, Mol. Endocrinol., 2012, 26, (4) 574–582.
D. Damian, Y. J. Kim, K. M. Dixon, G. M. Halliday, A. Javeri and R. S. Mason, Topical calcitriol protects from UV-induced genetic damage but suppresses immunity in humans, Exp. Dermatol., 2010, 19, e23–e30.
G. H. Posner, H. B. Jeon, A. Sarjeant, E. S. Riccio, R. S. Doppalapudi, I. M. Kapetanovic, U. Saha, P. Dolan and T. W. Kensler, Low-calcemic, efficacious, 1α,25-dihydroxyvitamin D3 analog QW-1624F2-2: calcemic dose-response determination, preclinical genotoxicity testing, and revision of A-ring stereochemistry, Steroids, 2004, 69, 757–762.
C. D. Reddy, R. Patti, A. Guttapalli, J. M. Maris, N. Yanamandra, A. Rachamallu, L. N. Sutton, P. C. Phillips and G. H. Posner, Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma, J. Cell. Biochem., 2006, 97, 198–206.
T. W. Kensler, P. M. Dolan, S. J. Gange, J. K. Lee, Q. Wang and G. H. Posner, Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis, Carcinogenesis, 2000, 21, 1341–1345.
G. H. Posner, J. K. Lee, Q. Wang, S. Peleg, M. Burke, H. Brem, P. Dolan and T. W. Kensler, Noncalcemic, antiproliferative, transcriptionally active, 24-fluorinated hybrid analogues of the hormone 1alpha, 25-dihydroxyvitamin D3. Synthesis and preliminary biological evaluation, J. Med. Chem., 1998, 41, 3008–3014.
C. Gordon-Thomson, R. S. Mason and G. P. Moore, Regulation of epidermal growth factor receptor expression in human melanocytes, Exp. Dermatol., 2001, 10, 321–328.
S. D. McLeod, C. Smith and R. S. Mason, Stimulation of tyrosinase in human melanocytes by pro-opiomelanocortin-derived peptides, J. Endocrinol., 1995, 146, 439–447.
L. Roza, K. J. van der Wulp, S. J. MacFarlane, P. H. Lohman and R. A. Baan, Detection of cyclobutane thymine dimers in DNA of human cells with monoclonal antibodies raised against a thymine dimer-containing tetranucleotide, Photochem. Photobiol., 1988, 48, 627–633.
V. E. Reeve, Ultraviolet radiation and the contact hypersensitivity reaction in mice, Methods, 2002, 28, 20–24.
V. E. Reeve and R. D. Ley, Animal models of ultraviolet radiation-induced skin cancer, in Prevention of Skin Cancer, ed. D. Hill, J. M. Elwood and D. R. English, Kluwer, Dordrecht, 2004, pp. 177–194.
Author information
Authors and Affiliations
Corresponding author
Additional information
Contribution to the Vitamin D Update collected papers.
Rights and permissions
About this article
Cite this article
Dixon, K.M., Sequeira, V.B., Deo, S.S. et al. Differential photoprotective effects of 1,25-dihydroxyvitamin D3 and a low calcaemic deltanoid. Photochem Photobiol Sci 11, 1825–1830 (2012). https://doi.org/10.1039/c2pp25208b
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c2pp25208b